Mold prompts recall of 5,000 vials of J&J's Risperdal Consta

Johnson & Johnson recalled an estimated 5,000 of the 70,000 vials of antipsychotic drug Risperdal Consta manufactured in one lot last year after testing positive for Alternaria alternata mold during routine quality inspection. The products must be pulled because they remain unused in pharmacies, community mental health centers and doctor's offices.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT